Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4031)
All Articles published online
|
Dec 7, 2011 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Zhang SP, Wang Z, Wang LX, Liu SJ. AG490: An inhibitor of hepcidin expression |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i45/5032.htm |
| Number | Citing Articles |
| 1 |
Cadiele Oliana Reichert, Joel da Cunha, Débora Levy, Luciana Morganti Ferreira Maselli, Sérgio Paulo Bydlowski, Celso Spada. Genetic Polymorphisms. 2017; doi: 10.5772/intechopen.69507
|
| 2 |
Nicole L. Blanchette, David H. Manz, Frank M. Torti, Suzy V. Torti. Modulation of hepcidin to treat iron deregulation: potential clinical applications. Expert Review of Hematology 2016; 9(2): 169 doi: 10.1586/17474086.2016.1124757
|
| 3 |
Bart J. Crielaard, Twan Lammers, Stefano Rivella. Targeting iron metabolism in drug discovery and delivery. Nature Reviews Drug Discovery 2017; 16(6): 400 doi: 10.1038/nrd.2016.248
|
| 4 |
Shilpa Rana, Nirmal Prabhakar. Iron disorders and hepcidin. Clinica Chimica Acta 2021; 523: 454 doi: 10.1016/j.cca.2021.10.032
|
| 5 |
Jolanta Malyszko, Jacek S. Malyszko, Joanna Matuszkiewicz-Rowinska. Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease. Expert Opinion on Therapeutic Targets 2019; 23(5): 407 doi: 10.1080/14728222.2019.1599358
|
| 6 |
Cadiele Oliana Reichert, Joel da Cunha, Débora Levy, Luciana Morganti Ferreira Maselli, Sérgio Paulo Bydlowski, Celso Spada. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism. Acta Haematologica 2017; 137(4): 220 doi: 10.1159/000471838
|
| 7 |
Zorislava Bajić, Nenad Ponorac, Amela Matavulj. The role of hepcidin in iron metabolism in athletes. Fizicka kultura 2019; 73(2): 206 doi: 10.5937/fizkul1902206B
|
| 8 |
Angeliki Katsarou, Kostas Pantopoulos. Hepcidin Therapeutics. Pharmaceuticals 2018; 11(4): 127 doi: 10.3390/ph11040127
|
| 9 |
Natalia Murawska, Adam Fabisiak, Jakub Fichna. Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2016; 22(5): 1198 doi: 10.1097/MIB.0000000000000648
|
| 10 |
Susana Conde Diez, Ricardo de las Cuevas Allende, Eulogio Conde García. Estado actual del metabolismo del hierro: implicaciones clínicas y terapéuticas. Medicina Clínica 2017; 148(5): 218 doi: 10.1016/j.medcli.2016.10.047
|
| 11 |
Wenli Guo, Shuping Zhang, Yue Chen, Daoqiang Zhang, Lin Yuan, Haibo Cong, Sijin Liu. An important role of the hepcidin–ferroportin signaling in affecting tumor growth and metastasis. Acta Biochimica et Biophysica Sinica 2015; 47(9): 703 doi: 10.1093/abbs/gmv063
|
| 12 |
Ningning Zhao, An-Sheng Zhang, Caroline A. Enns. Iron regulation by hepcidin. Journal of Clinical Investigation 2013; 123(6): 2337 doi: 10.1172/JCI67225
|
| 13 |
Wei-Na Kong, Guofen Gao, Yan-Zhong Chang. Hepcidin and sports anemia. Cell & Bioscience 2014; 4(1) doi: 10.1186/2045-3701-4-19
|
| 14 |
Jelena Damm, Lois May Harden, Rüdiger Gerstberger, Joachim Roth, Christoph Rummel. The putative JAK-STAT inhibitor AG490 exacerbates LPS-fever, reduces sickness behavior, and alters the expression of pro- and anti-inflammatory genes in the rat brain. Neuropharmacology 2013; 71: 98 doi: 10.1016/j.neuropharm.2013.03.014
|
| 15 |
Ricardo de las Cuevas Allende, Lucía Díaz de Entresotos, Susana Conde Díez. Anaemia of chronic diseases: Pathophysiology, diagnosis and treatment. Medicina Clínica (English Edition) 2021; 156(5): 235 doi: 10.1016/j.medcle.2020.07.022
|
| 16 |
Maura Poli, Michela Asperti, Paola Ruzzenenti, Maria Regoni, Paolo Arosio. Hepcidin antagonists for potential treatments of disorders with hepcidin excess. Frontiers in Pharmacology 2014; 5 doi: 10.3389/fphar.2014.00086
|
| 17 |
Ricardo de las Cuevas Allende, Lucía Díaz de Entresotos, Susana Conde Díez. Anemia de las enfermedades crónicas: fisiopatología, diagnóstico y tratamiento. Medicina Clínica 2021; 156(5): 235 doi: 10.1016/j.medcli.2020.07.035
|
| 18 |
Arielle L. Langer, Yelena Z. Ginzburg. Role of hepcidin‐ferroportin axis in the pathophysiology, diagnosis, and treatment of anemia of chronic inflammation. Hemodialysis International 2017; 21(S1) doi: 10.1111/hdi.12543
|
| 19 |
Fali Zhang, Peng Zhao, Zhongming Qian, Mingkang Zhong. Central Nervous System Inflammation Induced by Lipopolysaccharide Up-Regulates Hepatic Hepcidin Expression by Activating the IL-6/JAK2/STAT3 Pathway in Mice. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.649640
|
| 20 |
Giada Sebastiani, Nicole Wilkinson, Kostas Pantopoulos. Pharmacological Targeting of the Hepcidin/Ferroportin Axis. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00160
|
| 21 |
Therapeutic potential of hepcidin − the master regulator of iron metabolism. Pharmacological Research 2017; 115: 242 doi: 10.1016/j.phrs.2016.11.010
|
| 22 |
Stanzin Angmo, Shilpa Rana, Kamalendra Yadav, Rajat Sandhir, Nitin Kumar Singhal. Novel Liposome Eencapsulated Guanosine Di Phosphate based Therapeutic Target against Anemia of Inflammation. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-35992-2
|
| 23 |
Zachary J. Hawula, Daniel F. Wallace, V. Nathan Subramaniam, Gautam Rishi. Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis. Pharmaceuticals 2019; 12(4): 170 doi: 10.3390/ph12040170
|
| 24 |
Susana Conde Diez, Ricardo de las Cuevas Allende, Eulogio Conde García. Current status of iron metabolism: Clinical and therapeutic implications. Medicina Clínica (English Edition) 2017; 148(5): 218 doi: 10.1016/j.medcle.2017.03.001
|
| 25 |
Jing Liu, Bingbing Sun, Huijun Yin, Sijin Liu. Hepcidin. Medicine 2016; 95(14): e3150 doi: 10.1097/MD.0000000000003150
|
| 26 |
Francisca Alcayaga-Miranda, Jimena Cuenca, Maroun Khoury. Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00339
|
| 27 |
Shuzhen Liu, Dongmei Yu, Peng Wei, Jiansheng Cai, Min Xu, Haoyu He, Xu Tang, Chuntao Nong, Yi Wei, Xia Xu, Xiaoting Mo, Zhiyong Zhang, Jian Qin. JAK2/STAT3 Signaling Pathway and Klotho Gene in Cadmium-induced Neurotoxicity In Vitro and In Vivo. Biological Trace Element Research 2023; 201(6): 2854 doi: 10.1007/s12011-022-03370-9
|
| 28 |
Erin Gaffney-Stomberg, James P. McClung. Inflammation and diminished iron status. Current Opinion in Clinical Nutrition and Metabolic Care 2012; 15(6): 605 doi: 10.1097/MCO.0b013e328357f63b
|
| 29 |
Yelena Z. Ginzburg. Iron Metabolism: Hepcidin. Vitamins and Hormones 2019; 110: 17 doi: 10.1016/bs.vh.2019.01.002
|
| 30 |
Yelena Z. Ginzburg. Hormone Receptors: Structures and Functions. Vitamins and Hormones 2023; 123: 249 doi: 10.1016/bs.vh.2023.03.001
|